[1]
Judson, M.A. et al. 2018. Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: A pilot, open label study. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 35, 3 (Oct. 2018), 192–197. DOI:https://doi.org/10.36141/svdld.v35i3.6917.